Technoclone Herstellung von Diagnostika und Arzneimitteln

Technoclone is committed to providing high-quality in vitro hemostasis diagnostic testing systems for its global customers. At Technoclone, innovation is regarded as a responsibility to address the complexities arising in the diagnosis of blood and cardiovascular diseases. Since 1987, Technoclone has established close cooperative relationships with global partners from academia, clinical laboratories, and the industry, positioning itself at the forefront of anticipated diagnostic challenges in the coming years.